EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A modified model of PANoptosisto identify prognosis and immunotherapy response in bladder cancer

Weichao Lv, Xiaohang Lei, Hongyuan Wang, Tongtong Wang, Jianguo Zhang

The International Journal of Biochemistry & Cell Biology · 2024

DOI: 10.1016/j.biocel.2024.106672 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The International Journal of Biochemistry & Cell Biology, 2024. Verfasst von Weichao Lv und 4 weiteren Autor:innen. Beteiligte Einrichtung: Urinary Surgery, New District Hospital of the First Affiliated Hospital of Henan University of Science and Technology, No.636 Guanlin Road, Luolong D…. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Immunotherapy. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Cell death, including apoptosis and necrosis, collectively known as widespread apoptosis. The present study aims to investigate the mechanism of action in widespread apoptosis-related modification patterns in bladder cancer. METHODS: Using a clinical genomics database, we obtained transcriptomic data and related clinical information of bladder cancer patients. By employing the least absolute shrinkage analysis, we were able to construct a risk model and single-cell sequencing analysis of differential genes in bladder cancer. RESULTS: Five differentially expressed genes (TMPRSS4, TPST1, FOXD1, ELOVL4, EMP1) associated with widespread apoptosis were identified as features for predicting the prognosis of bladder cancer patients. Survival curve analysis revealed significant differences in prognosis (P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsImmunotherapyHumansPrognosisMaleBiomarkers, TumorFemaleGene Expression Regulation, NeoplasticApoptosisSingle-Cell AnalysisAgedMiddle AgedTranscriptomeCyclin-Dependent Kinase Inhibitor p16

Stichwörter der Autor:innen

Bladder cancerImmunotherapyPrognosisScoring modelWidespread apoptosis

Substanzen

Biomarkers, TumorCyclin-Dependent Kinase Inhibitor p16

Autor:innen und Institutionen

  • Urinary Surgery, New District Hospital of the First Affiliated Hospital of Henan University of Science and Technology, No.636 Guanlin Road, Luolong District, Luoyang, Henan 471000, China.
  • Health management center, Luoyang Third People's Hospital, No.560, Chanshanjian Avenue, Chanshuihe District, Luoyang 471002, China.
  • Urinary Surgery, New District Hospital of the First Affiliated Hospital of Henan University of Science and Technology, No.636 Guanlin Road, Luolong District, Luoyang, Henan 471000, China. Electronic address: hkdyfyzjg@1…

Zitieren

APA

Lv, W., Lei, X., Wang, H., Wang, T., & Zhang, J. (2024). A modified model of PANoptosisto identify prognosis and immunotherapy response in bladder cancer. The International Journal of Biochemistry & Cell Biology. https://doi.org/10.1016/j.biocel.2024.106672

Vancouver

Lv W, Lei X, Wang H, Wang T, Zhang J. A modified model of PANoptosisto identify prognosis and immunotherapy response in bladder cancer. The International Journal of Biochemistry & Cell Biology. 2024. doi:10.1016/j.biocel.2024.106672

BibTeX
@article{Lv2024,
  author = {Lv, Weichao and Lei, Xiaohang and Wang, Hongyuan and Wang, Tongtong and Zhang, Jianguo},
  title = {A modified model of PANoptosisto identify prognosis and immunotherapy response in bladder cancer},
  journal = {The International Journal of Biochemistry & Cell Biology},
  year = {2024},
  doi = {10.1016/j.biocel.2024.106672}
}
Kostenlos starten →